Selected research
Industry Research
Home-Care Diagnostics Kit Industry Research Report 2026
Market perspective
The global Home-Care Diagnostics Kit market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Home-Care Diagnostics Kit market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Home-Care Diagnostics Kit market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Home-Care Diagnostics Kit market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Home-Care Diagnostics Kit include Acon, ARKRAY, Ascensia, BlueCross, Cyclotest, Easy@Home, Fairhaven Health, First Response and Gregory Pharmaceutical (e.p.t), among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Home-Care Diagnostics Kit market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Home-Care Diagnostics Kit.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Home-Care Diagnostics Kit Market by Company
Acon
ARKRAY
Ascensia
BlueCross
Cyclotest
Easy@Home
Fairhaven Health
First Response
Gregory Pharmaceutical (e.p.t)
I-SENS
Lifescan
Omron
PRIMA Lab
RunBio
Sinocare
SPD (Clearblue)
Wondfo
Yicheng
Yuwell
B. Braun
Roche
Abbott
Home-Care Diagnostics Kit Segment by Type
Blood Glucose Testing
Ovulation and Pregnancy Test Kits
Other
Home-Care Diagnostics Kit Segment by Application
Hospital
Retail Pharmacy
Other
Home-Care Diagnostics Kit Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Home-Care Diagnostics Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Home-Care Diagnostics Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Home-Care Diagnostics Kit.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Home-Care Diagnostics Kit companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Blood Glucose Testing
- Ovulation and Pregnancy Test Kits
- Other
Applications
- Hospital
- Retail Pharmacy
- Other
Companies covered
- Acon
- ARKRAY
- Ascensia
- BlueCross
- Cyclotest
- Easy@Home
- Fairhaven Health
- First Response
- Gregory Pharmaceutical (e.p.t)
- I-SENS
- Lifescan
- Omron
- PRIMA Lab
- RunBio
- Sinocare
- SPD (Clearblue)
- Wondfo
- Yicheng
- Yuwell
- B. Braun
- Roche
- Abbott
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Home-Care Diagnostics Kit by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Blood Glucose Testing
- 2.2.3 Ovulation and Pregnancy Test Kits
- 2.2.4 Other
- 2.3 Home-Care Diagnostics Kit by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital
- 2.3.3 Retail Pharmacy
- 2.3.4 Other
- 2.4 Assumptions and Limitations
3 Home-Care Diagnostics Kit Breakdown Data by Type
- 3.1 Global Home-Care Diagnostics Kit Historic Market Size by Type (2021-2026)
- 3.2 Global Home-Care Diagnostics Kit Forecasted Market Size by Type (2027-2032)
4 Home-Care Diagnostics Kit Breakdown Data by Application
- 4.1 Global Home-Care Diagnostics Kit Historic Market Size by Application (2021-2026)
- 4.2 Global Home-Care Diagnostics Kit Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Home-Care Diagnostics Kit Market Perspective (2021-2032)
- 5.2 Global Home-Care Diagnostics Kit Growth Trends by Region
- 5.2.1 Global Home-Care Diagnostics Kit Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Home-Care Diagnostics Kit Historic Market Size by Region (2021-2026)
- 5.2.3 Home-Care Diagnostics Kit Forecasted Market Size by Region (2027-2032)
- 5.3 Home-Care Diagnostics Kit Market Dynamics
- 5.3.1 Home-Care Diagnostics Kit Industry Trends
- 5.3.2 Home-Care Diagnostics Kit Market Drivers
- 5.3.3 Home-Care Diagnostics Kit Market Challenges
- 5.3.4 Home-Care Diagnostics Kit Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Home-Care Diagnostics Kit Players by Revenue
- 6.1.1 Global Top Home-Care Diagnostics Kit Players by Revenue (2021-2026)
- 6.1.2 Global Home-Care Diagnostics Kit Revenue Market Share by Players (2021-2026)
- 6.2 Global Home-Care Diagnostics Kit Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Home-Care Diagnostics Kit Head Office and Area Served
- 6.4 Global Home-Care Diagnostics Kit Players, Product Type & Application
- 6.5 Global Home-Care Diagnostics Kit Manufacturers Established Date
- 6.6 Global Home-Care Diagnostics Kit Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Home-Care Diagnostics Kit Market Size (2021-2032)
- 7.2 North America Home-Care Diagnostics Kit Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Home-Care Diagnostics Kit Market Size by Country (2021-2026)
- 7.4 North America Home-Care Diagnostics Kit Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Home-Care Diagnostics Kit Market Size (2021-2032)
- 8.2 Europe Home-Care Diagnostics Kit Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Home-Care Diagnostics Kit Market Size by Country (2021-2026)
- 8.4 Europe Home-Care Diagnostics Kit Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Home-Care Diagnostics Kit Market Size (2021-2032)
- 9.2 Asia-Pacific Home-Care Diagnostics Kit Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Home-Care Diagnostics Kit Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Home-Care Diagnostics Kit Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Home-Care Diagnostics Kit Market Size (2021-2032)
- 10.2 South America Home-Care Diagnostics Kit Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Home-Care Diagnostics Kit Market Size by Country (2021-2026)
- 10.4 South America Home-Care Diagnostics Kit Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Home-Care Diagnostics Kit Market Size (2021-2032)
- 11.2 Middle East & Africa Home-Care Diagnostics Kit Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Home-Care Diagnostics Kit Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Home-Care Diagnostics Kit Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Acon
- 12.1.1 Acon Company Information
- 12.1.2 Acon Business Overview
- 12.1.3 Acon Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.1.4 Acon Home-Care Diagnostics Kit Product Portfolio
- 12.1.5 Acon Recent Developments
- 12.2 ARKRAY
- 12.2.1 ARKRAY Company Information
- 12.2.2 ARKRAY Business Overview
- 12.2.3 ARKRAY Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.2.4 ARKRAY Home-Care Diagnostics Kit Product Portfolio
- 12.2.5 ARKRAY Recent Developments
- 12.3 Ascensia
- 12.3.1 Ascensia Company Information
- 12.3.2 Ascensia Business Overview
- 12.3.3 Ascensia Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.3.4 Ascensia Home-Care Diagnostics Kit Product Portfolio
- 12.3.5 Ascensia Recent Developments
- 12.4 BlueCross
- 12.4.1 BlueCross Company Information
- 12.4.2 BlueCross Business Overview
- 12.4.3 BlueCross Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.4.4 BlueCross Home-Care Diagnostics Kit Product Portfolio
- 12.4.5 BlueCross Recent Developments
- 12.5 Cyclotest
- 12.5.1 Cyclotest Company Information
- 12.5.2 Cyclotest Business Overview
- 12.5.3 Cyclotest Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.5.4 Cyclotest Home-Care Diagnostics Kit Product Portfolio
- 12.5.5 Cyclotest Recent Developments
- 12.6 Easy@Home
- 12.6.1 Easy@Home Company Information
- 12.6.2 Easy@Home Business Overview
- 12.6.3 Easy@Home Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.6.4 Easy@Home Home-Care Diagnostics Kit Product Portfolio
- 12.6.5 Easy@Home Recent Developments
- 12.7 Fairhaven Health
- 12.7.1 Fairhaven Health Company Information
- 12.7.2 Fairhaven Health Business Overview
- 12.7.3 Fairhaven Health Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.7.4 Fairhaven Health Home-Care Diagnostics Kit Product Portfolio
- 12.7.5 Fairhaven Health Recent Developments
- 12.8 First Response
- 12.8.1 First Response Company Information
- 12.8.2 First Response Business Overview
- 12.8.3 First Response Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.8.4 First Response Home-Care Diagnostics Kit Product Portfolio
- 12.8.5 First Response Recent Developments
- 12.9 Gregory Pharmaceutical (e.p.t)
- 12.9.1 Gregory Pharmaceutical (e.p.t) Company Information
- 12.9.2 Gregory Pharmaceutical (e.p.t) Business Overview
- 12.9.3 Gregory Pharmaceutical (e.p.t) Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.9.4 Gregory Pharmaceutical (e.p.t) Home-Care Diagnostics Kit Product Portfolio
- 12.9.5 Gregory Pharmaceutical (e.p.t) Recent Developments
- 12.10 I-SENS
- 12.10.1 I-SENS Company Information
- 12.10.2 I-SENS Business Overview
- 12.10.3 I-SENS Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.10.4 I-SENS Home-Care Diagnostics Kit Product Portfolio
- 12.10.5 I-SENS Recent Developments
- 12.11 Lifescan
- 12.11.1 Lifescan Company Information
- 12.11.2 Lifescan Business Overview
- 12.11.3 Lifescan Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.11.4 Lifescan Home-Care Diagnostics Kit Product Portfolio
- 12.11.5 Lifescan Recent Developments
- 12.12 Omron
- 12.12.1 Omron Company Information
- 12.12.2 Omron Business Overview
- 12.12.3 Omron Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.12.4 Omron Home-Care Diagnostics Kit Product Portfolio
- 12.12.5 Omron Recent Developments
- 12.13 PRIMA Lab
- 12.13.1 PRIMA Lab Company Information
- 12.13.2 PRIMA Lab Business Overview
- 12.13.3 PRIMA Lab Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.13.4 PRIMA Lab Home-Care Diagnostics Kit Product Portfolio
- 12.13.5 PRIMA Lab Recent Developments
- 12.14 RunBio
- 12.14.1 RunBio Company Information
- 12.14.2 RunBio Business Overview
- 12.14.3 RunBio Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.14.4 RunBio Home-Care Diagnostics Kit Product Portfolio
- 12.14.5 RunBio Recent Developments
- 12.15 Sinocare
- 12.15.1 Sinocare Company Information
- 12.15.2 Sinocare Business Overview
- 12.15.3 Sinocare Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.15.4 Sinocare Home-Care Diagnostics Kit Product Portfolio
- 12.15.5 Sinocare Recent Developments
- 12.16 SPD (Clearblue)
- 12.16.1 SPD (Clearblue) Company Information
- 12.16.2 SPD (Clearblue) Business Overview
- 12.16.3 SPD (Clearblue) Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.16.4 SPD (Clearblue) Home-Care Diagnostics Kit Product Portfolio
- 12.16.5 SPD (Clearblue) Recent Developments
- 12.17 Wondfo
- 12.17.1 Wondfo Company Information
- 12.17.2 Wondfo Business Overview
- 12.17.3 Wondfo Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.17.4 Wondfo Home-Care Diagnostics Kit Product Portfolio
- 12.17.5 Wondfo Recent Developments
- 12.18 Yicheng
- 12.18.1 Yicheng Company Information
- 12.18.2 Yicheng Business Overview
- 12.18.3 Yicheng Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.18.4 Yicheng Home-Care Diagnostics Kit Product Portfolio
- 12.18.5 Yicheng Recent Developments
- 12.19 Yuwell
- 12.19.1 Yuwell Company Information
- 12.19.2 Yuwell Business Overview
- 12.19.3 Yuwell Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.19.4 Yuwell Home-Care Diagnostics Kit Product Portfolio
- 12.19.5 Yuwell Recent Developments
- 12.20 B. Braun
- 12.20.1 B. Braun Company Information
- 12.20.2 B. Braun Business Overview
- 12.20.3 B. Braun Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.20.4 B. Braun Home-Care Diagnostics Kit Product Portfolio
- 12.20.5 B. Braun Recent Developments
- 12.21 Roche
- 12.21.1 Roche Company Information
- 12.21.2 Roche Business Overview
- 12.21.3 Roche Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.21.4 Roche Home-Care Diagnostics Kit Product Portfolio
- 12.21.5 Roche Recent Developments
- 12.22 Abbott
- 12.22.1 Abbott Company Information
- 12.22.2 Abbott Business Overview
- 12.22.3 Abbott Revenue in Home-Care Diagnostics Kit Business (2021-2026)
- 12.22.4 Abbott Home-Care Diagnostics Kit Product Portfolio
- 12.22.5 Abbott Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst